Compare · ALB vs ZTEK
ALB vs ZTEK
Side-by-side comparison of Albemarle Corporation (ALB) and Zentek Ltd. (ZTEK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALB and ZTEK operate in Major Chemicals (Industrials), so they compete in similar markets.
- ALB is the larger of the two at $22.20B, about 439.1x ZTEK ($50.6M).
- Over the past year, ALB is up 221.7% and ZTEK is down 67.6% - ALB leads by 289.2 points.
- ZTEK has been more active in the news (6 items in the past 4 weeks vs 5 for ALB).
- ALB has more recent analyst coverage (25 ratings vs 0 for ZTEK).
- Company
- Albemarle Corporation
- Zentek Ltd.
- Price
- $188.34-2.47%
- $0.48-5.08%
- Market cap
- $22.20B
- $50.6M
- 1M return
- +3.75%
- -17.19%
- 1Y return
- +221.67%
- -67.55%
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 5
- 6
- Recent ratings
- 25
- 0
Albemarle Corporation
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine Specialties segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines, biocides, disinfectants, and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Zentek Ltd.
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.
Latest ALB
- Albemarle downgraded by Rothschild & Co Redburn with a new price target
- Albemarle Corporation filed SEC Form 8-K: Leadership Update
- Albemarle downgraded by Robert W. Baird with a new price target
- Scaling Lithium Operations to Meet Surging Global Demand
- Albemarle Corporation to Release First Quarter 2026 Earnings Results on Wednesday, May 6, 2026
- SEC Form 4 filed by Wolff Alejandro Daniel
- Amendment: SEC Form 10-K/A filed by Albemarle Corporation
- Amendment: SEC Form SCHEDULE 13G/A filed by Albemarle Corporation
- Albemarle Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- SEC Form DEFA14A filed by Albemarle Corporation
Latest ZTEK
- SEC Form 6-K filed by Zentek Ltd.
- SEC Form 6-K filed by Zentek Ltd.
- SEC Form 6-K filed by Zentek Ltd.
- SEC Form 6-K filed by Zentek Ltd.
- SEC Form 6-K filed by Zentek Ltd.
- Albany Graphite Corp. Engages Micon International to Complete New PEA for Albany Graphite Project
- SEC Form 6-K filed by Zentek Ltd.
- SEC Form 6-K filed by Zentek Ltd.
- Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification
- SEC Form 6-K filed by Zentek Ltd.